fibrinogen has been researched along with Hemangioma Thrombocytopenia Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KL; Cohen, S; Sangueza, OP; Taylor, SL | 1 |
| Chen, M; Jiang, H; Liu, Z; Shen, G; Tan, X; Xia, J; Zhang, J; Zhou, S | 1 |
2 other study(ies) available for fibrinogen and Hemangioma Thrombocytopenia Syndrome
| Article | Year |
|---|---|
Tufted angioma presenting with subclinical coagulopathy.
Topics: Asymptomatic Diseases; Biopsy; Blood Coagulation Disorders; Diagnosis, Differential; Erythema; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemangioma; Humans; Infant; Kasabach-Merritt Syndrome; Male; Skin Neoplasms | 2019 |
Treatment of Corticosteroid-Resistant Vascular Tumors Associated with the Kasabach-Merritt Phenomenon in Infants: An Approach with Transcatheter Arterial Embolization Plus Vincristine Therapy.
Topics: Administration, Intravenous; Adrenal Cortex Hormones; Antineoplastic Agents, Phytogenic; Blood Platelets; Chemoembolization, Therapeutic; Dexamethasone; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Fibrinogen; Humans; Infant; Kasabach-Merritt Syndrome; Male; Platelet Count; Retrospective Studies; Time Factors; Treatment Outcome; Vincristine | 2016 |